Literature DB >> 2713780

Urinary excretion of pentoxifylline and its metabolites by standardbred mares.

E C Kwong1, F C Chen, L M Young.   

Abstract

The urinary excretion of a sustained-release formulation of pentoxifylline was studied in the horse after the oral administration of 4.0 grams of Trental tablets. Urine samples were collected for 24 hours after dosing and analyzed for pentoxifylline and its metabolites using high-performance liquid chromatography coupled with an ultraviolet detector. Six metabolites of pentoxifylline were identified in horse urine in addition to less than 0.2% of unchanged drug. Concomitant use of gas chromatography/mass spectrometry allowed for the elucidation of the chemical structures of the metabolites. Metabolism of pentoxifylline yields one demethylated derivative, four hydroxylated metabolites and a conjugate of one of the hydroxymetabolites as urine products. The demethylated derivative, 3-methyl-1-(5-oxohexyl)-xanthine, was found to be the predominant metabolite in the urine.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2713780      PMCID: PMC1255539     

Source DB:  PubMed          Journal:  Can J Vet Res        ISSN: 0830-9000            Impact factor:   1.310


  14 in total

1.  A study of the metabolism of theobromine, theophylline, and caffeine in man.

Authors:  H H CORNISH; A A CHRISTMAN
Journal:  J Biol Chem       Date:  1957-09       Impact factor: 5.157

2.  Absorption, distribution, excretion, and metabolism of 1-(5-oxohexyl) theobromine (BL 191) in rats.

Authors:  K Fujimoto; S Yoshida; Y Moriyama; T Sakaguchi
Journal:  Chem Pharm Bull (Tokyo)       Date:  1976-06       Impact factor: 1.645

3.  [Structure of excretion products of 3,7-dimethyl-1-(5-oxo-hemyl)-xanthine (BL 191) in man].

Authors:  H J Hinze; G Bedessem; A Söder
Journal:  Arzneimittelforschung       Date:  1972-07

4.  [Pharmacokinetics of 3,7-dimethyl-1-(5-oxo-hexyl)-xanthine (BL 191) in man].

Authors:  H J Hinze
Journal:  Arzneimittelforschung       Date:  1972-09

5.  Determination of 1-(3'-carboxypropyl)-3,7-dimethylxanthine and 1-(4'-carboxybutyl)-3,7-dimethylxanthine, two major metabolites of oxpentifylline, in urine by high-performance liquid chromatography.

Authors:  T A Bryce; J L Burrows; K W Jolley
Journal:  J Chromatogr       Date:  1985-11-08

6.  Simultaneous determination of pentoxifylline and its hydroxy metabolite in plasma by high-performance liquid chromatography.

Authors:  D A Chivers; D J Birkett; J O Miners
Journal:  J Chromatogr       Date:  1981-09-11

7.  A preliminary report on the use of warfarin in the treatment of navicular disease.

Authors:  C M Colles
Journal:  Equine Vet J       Date:  1979-07       Impact factor: 2.888

8.  Gas chromatographic determination of pentoxifylline and its major metabolites in human breast milk.

Authors:  M T Bauza; R V Smith; D E Knutson; F R Witter
Journal:  J Chromatogr       Date:  1984-09-14

9.  Determination of oxpentifylline and a metabolite, 1-(5'-hydroxyhexyl)-3,7-dimethylxanthine, by gas--liquid chromatography using a nitrogen-selective detector.

Authors:  T A Bryce; J L Burrows
Journal:  J Chromatogr       Date:  1980-03-14

10.  Kinetics of intravenous and oral pentoxifylline in healthy subjects.

Authors:  B Beermann; R Ings; J Månsby; J Chamberlain; A McDonald
Journal:  Clin Pharmacol Ther       Date:  1985-01       Impact factor: 6.875

View more
  1 in total

1.  Effects of pentoxifylline on equine neutrophil function and flow properties.

Authors:  D J Weiss; R J Geor; S M Burris; C M Smith
Journal:  Can J Vet Res       Date:  1992-10       Impact factor: 1.310

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.